Impact BioMedical
10 hedge funds and large institutions have $76.1K invested in Impact BioMedical in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
28% more capital invested
Capital invested by funds: $59.3K → $76.1K (+$16.8K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
11% more funds holding
Funds holding: 9 → 10 (+1)
0.2% more ownership
Funds ownership: 0.26% → 0.46% (+0.2%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$43.1K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$26.1K |
| 3 |
State Street
Boston,
Massachusetts
|
+$23.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.81K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$26.7K |
| 2 |
HF
HRT Financial
New York
|
-$25K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$5.35K |
| 4 |
Barclays
London,
United Kingdom
|
-$2.24K |
| 5 |
Morgan Stanley
New York
|
-$116 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $30.1K | +$43.1K | +20,774 | New |
|
|
FIA
2
FNY Investment Advisers
New York
| $18K | +$26.1K | +12,600 | New |
|
|
3
State Street
Boston,
Massachusetts
| $16.2K | +$23.2K | +11,171 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $6.17K | +$8.81K | +4,249 | +141,633% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $5.45K | +$7.8K | +3,760 | New |
|
|
NFSG
6
Newbridge Financial Services Group
Boca Raton,
Florida
| $125 | +$178 | +86 | New |
|
7
Wells Fargo
San Francisco,
California
| $42 | – | – | – |
|
|
8
Bank of America
Charlotte,
North Carolina
| $24 | -$5.35K | -2,579 | -99% |
|
|
DB
9
Danske Bank
Copenhagen K,
Denmark
| $4 | – | – | – |
|
10
Group One Trading
Chicago,
Illinois
| $1 | – | – | – |
|
|
11
Jane Street
New York
| – | -$26.7K | -13,361 | Closed |
|
|
HF
12
HRT Financial
New York
| – | -$25K | -12,502 | Closed |
|
|
13
Barclays
London,
United Kingdom
| – | -$2.24K | -1,120 | Closed |
|
|
14
Morgan Stanley
New York
| – | -$116 | -58 | Closed |
|
IBO Hedge Fund Activity: Q4 2024 in Review
10 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Impact BioMedical (IBO) for Q4 2024, worth a combined $76.1K — up 28% from $59.3K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IBO positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $43.1K. The largest seller was Jane Street, exiting entirely with an estimated $26.7K sold.
- 10 institutional investors held Impact BioMedical (IBO) as of Q4 2024, up from 9 in Q3 2024.
- Funds reported $76.1K of Impact BioMedical stock for Q4 2024, up 28% quarter-over-quarter.
- 5 funds opened new Impact BioMedical positions in Q4 2024 and 4 closed out, a net change of +1 holder.
- The largest Impact BioMedical buyer in Q4 2024 was Geode Capital Management, an estimated $43.1K added.
- The largest Impact BioMedical seller in Q4 2024 was Jane Street, an estimated $26.7K sold.
Based on aggregated 13F filings for Q4 2024.